DLBCL Clinical case: Adherence to the ESMO Clinical Practice Guidelines

As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer (1-not at all; 5-a lot).

Questions marked with are required.

1. Did your undertaking of this E-Learning module describe the current approach to diagnosis, staging and risk-assessment in patients with diffuse large B-cell lymphoma (DLBCL)?

2. Did your undertaking of this E-Learning module describe current treatment approaches in first-line, and relapsed/refractory DLBCL settings?

3. Did it help you understand attempts in the clinical studies to predict the outcome or increase the treatment efficacy in subsets of patients with DLBCL?

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module.

5. How would you rate the interactivity level offered in the E-Learning material?

6. Was the information useful and relevant to your work and practice?

7. Do you feel that the information presented was well balanced and supported by adequate evidence?

8. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: